investments

Accera is a biopharmaceutical company with a breakthrough drug for Alzheimer's in late stage clinical testing. Accera's pipeline consists of novel therapeutic drugs and medical foods for neurodegenerative diseases such as Alzheimer's, Parkinson's, and Age Associated Memory Impairment.


AM-Pharma is a biopharmaceutical company with novel therapeutics to treat inflammatory and infectious diseases in clinical development. The products are based on endogenous proteins and (protein derived) peptides.

Atonomics has developed a breakthrough point of care diagnostic device based on an innovative electro-mechanical concept. This technology will revolutionize the way that DNA and antibodies are used in point of care diagnosis.

Biolactis is specialized in the development of natural peptide mixtures for treatment and prevention of most common diseases like lipid disorders, cardio-vascular disorders, and metabolic syndrome and has also developed products for cosmeceutical applications.

Novel beverage concepts for kids - healthy fun beverages with a surprise gift, patent protected, on each bottle. One of the few beverages in the market specifically designed for kids, while most other kids beverages are just lesser volumes of existing products. Boowl products are on the shelf in major European markets and expanding rapidly.

CAP Technologies has developed re-closable lids for beverage cans - a technology that is poised to replace today's SOT-lids worldwide (some 200 bn cans per year). This unique, patented technology enables not only the sealed reclosing of alu cans, but also of PET and other packaging containers (liquids, powders, gels etc.).

Cavis Microcaps develops novel food grade capsules to deliver bioactives. The capsules are unique due to the multi-layer design which results in customized characteristics regarding stability and functionality. Applications range from food to cosmetic, chemical and pharma industries.

CMP Therapeutics has developed a novel treatment for regulating and stimulating the immune system. The lead product is in Phase II clinical trials for allergic disorders. Other pipeline products have shown through stimulation of the immune system to protect against viruses and bacteria.

Founded in 2003, as a spin-off from the Max Planck Institute for Infection Biology in Berlin (Germany) Creatogen develops bacterial carriers for oral delivery to treat and to prevent acute and chronic diseases caused by an imbalance of the immune system. Creatogen is in final development of a bird-flu vaccine for poultry.

Cryolog develops cost effective solutions to track freshness of temperature-sensitive products on an sku-level. The products range from standardized label "eO" and customized label "Traceo", to sophisticated "i-tag" which enclosed an RIFD chip. Clients are one of the world biggest caterers as well as major supermarket chains.

DiObex is a biopharmaceutical company that has one of the lead compounds for the treatment of type 2 diabetes via the innovative cortisol pathway in clinical testing. This new mechanism of action might also lead to the prevention of metabolic syndrome. Their pipeline includes products targeted at significant unmet medical needs in metabolic disorders including type 1 diabetes, dyslipidemia, obesity, and diabetic nephropathy.

EnCoate develops proprietary, cost effective, food-grade biopolymer technologies. These simple biopolymers have broad application in extending the shelf-life of food, pharmaceutical and agricultural products (such as probiotics) at ambient temperatures.

EverNutrition has developed and is marketing an innovative line of Everlast branded products with a focus on personal health and fitness. EverNutrition holds the exclusive rights for use of the Everlast brand on nutrition products sold in the USA, Canada and the UK.

Food Quality Sensor International, Inc. is a high technology sensor company focused on development and commercialization of first-of-a-kind, real-time, interactive meat freshness measurement devices for the food processing, grocery distribution, food service, regulatory, defense, and consumer retail markets.

Honest Tea is the leader in the organic Ready To Drink tea category in North America. A commitment to social responsibility is central to Honest Tea's identity and purpose. The company strives for authenticity, integrity and purity, in their products and in the way they do business. In addition to creating a healthy alternative beverage with a lot less sugar than most bottled drinks, Honest Tea seeks to create honest relationships with their employees, suppliers, customers and with the communities in which they do business.

Horizon Science has discovered and patented proprietary natural bioactives with two main effects: lowering the absorption of carbohydrate, and increasing ratio of lean muscle mass vs fat tissue. Independent studies by University of Sydney have proven that high carbohydrate food products combined with certain of these bioactives can be turned into "Low GI" (low glycemic index) food products (e.g. soft drinks and even normal sugar become Low GI). This discovery has the potential to revolutionize the sugar/sweetener industry both on the retail level, as well as, or  even more on the b-to-b level, similar to what NutraSweet® and Splenda® have achieved.

companies